Learn More
Medchemexpress LLC Crizotinib | 877399-52-5 | 99.7% | C21H22Cl2FN5O | 5 MG

Supplier: Medchemexpress LLC HY508785MG
Crizotinib is an orally bioavailable, ATP-competitive ALK, c-Met, and ROS1 inhibitor. It inhibits tyrosine phosphorylation of NPM-ALK and c-Met in cell-based assays. This compound demonstrates effective tumor growth inhibition and is for research use only, not for sale to patients.
- Orally bioavailable and ATP-competitive.
- Inhibits ALK, c-Met, and ROS1.
- Demonstrates effective tumor growth inhibition.
- Inhibits tyrosine phosphorylation of NPM-ALK and c-Met.
- Purity of 99.7%.
- Stable under recommended storage conditions.
- Suitable for research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.